[Impact of iatrogenic preterm birth on newborn morbidity]

E Beinder1

  • 1K linik für Geburtsmedizin, Charité-Universitätsmedizin, Berlin. Ernst.Beinder@charite.de

Insights

Premature birth rates are rising due to late preterm births. Standardized treatment algorithms for conditions like mild preeclampsia are needed to reduce these iatrogenic preterm births.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Public Health

Background:

  • The incidence of premature births is increasing in developed nations.
  • This rise is largely attributed to iatrogenic late preterm births (34 weeks + 0 days to 36 weeks + 6 days gestation).
  • Late preterm births constitute up to 80% of all preterm deliveries and are associated with increased neonatal morbidity, mortality, and long-term neurodevelopmental impairments compared to term infants.

Purpose of the Study:

  • To highlight the increasing trend of late preterm births.
  • To emphasize the associated adverse outcomes in newborns.
  • To advocate for the implementation of standardized treatment protocols to mitigate iatrogenic preterm births.

Main Methods:

  • Analysis of trends in preterm birth incidence.
  • Review of neonatal outcomes associated with late preterm births.
  • Identification of key clinical conditions contributing to iatrogenic preterm birth.

Main Results:

  • A discernible increase in the overall incidence of premature births.
  • Late preterm births are a significant contributor, accounting for a substantial majority of preterm deliveries.
  • Newborns born late preterm exhibit elevated risks for mortality and neurodevelopmental issues.

Conclusions:

  • There is an urgent need to address the rising rates of iatrogenic late preterm births.
  • Standardized treatment algorithms are crucial for managing conditions such as mild preeclampsia and intrauterine growth restriction.
  • Implementing evidence-based protocols can help reduce the incidence of preventable preterm births and improve neonatal outcomes.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...